These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice. Ceballos L; Elissondo C; Sánchez Bruni S; Denegri G; Lanusse C; Alvarez L Antimicrob Agents Chemother; 2011 Dec; 55(12):5861-7. PubMed ID: 21930885 [TBL] [Abstract][Full Text] [Related]
4. Experimental cystic echinococcosis therapy: In vitro and in vivo combined 5-fluorouracil/albendazole treatment. Pensel PE; Elissondo N; Gambino G; Gamboa GU; Benoit JP; Elissondo MC Vet Parasitol; 2017 Oct; 245():62-70. PubMed ID: 28969840 [TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst. Ahmadnia S; Moazeni M; Mohammadi-Samani S; Oryan A Exp Parasitol; 2013 Oct; 135(2):314-9. PubMed ID: 23912040 [TBL] [Abstract][Full Text] [Related]
6. Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis. Pensel PE; Castro S; Allemandi D; Bruni SS; Palma SD; Elissondo MC Vet Parasitol; 2014 Jun; 203(1-2):80-6. PubMed ID: 24572043 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice. Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050 [TBL] [Abstract][Full Text] [Related]
8. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep. Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888 [TBL] [Abstract][Full Text] [Related]
9. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice. Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481 [TBL] [Abstract][Full Text] [Related]
10. Could ivermectin have a synergic effect with albendazole in hydatidosis therapy? Moreno MJ; Casado N; Urrea-París MA; Rodríguez-Caabeiro F Parasitol Res; 2002 Jun; 88(6):563-7. PubMed ID: 12107480 [TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of the efficacy of combined albedazole-IFN-α treatment for cystic echinococcosis in mice. Zhang S; Zhou Y; Su L; Zhang X; Wang H; Liu B Parasitol Res; 2017 Feb; 116(2):735-742. PubMed ID: 27928681 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice. Vural G; Yardimci M; Kocak M; Yasar TÖ; Kurt A; Harem IS; Carradori S; Sciamanna I; Siles-Lucas M; Fabiani M; Hemphill A; Lundström-Stadelmann B; Cirilli R; Casulli A Parasitology; 2020 Nov; 147(13):1425-1432. PubMed ID: 32729453 [TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis. Farhadi M; Haniloo A; Rostamizadeh K; Ahmadi N Parasitol Res; 2021 Dec; 120(12):4049-4060. PubMed ID: 34669034 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice]. Liang W; Wang XC; Wu XW; Zhang SJ; Sun H; Ma X; Peng XY Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Jun; 32(3):188-92. PubMed ID: 25223052 [TBL] [Abstract][Full Text] [Related]
15. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations. Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects. Bakhtiar NM; Akbarzadeh A; Casulli A; Mahami-Oskouei M; Ahmadpour E; Nami S; Rostami A; Spotin A Parasitol Res; 2019 Sep; 118(9):2455-2466. PubMed ID: 31402401 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes. Torabi N; Dobakhti F; Faghihzadeh S; Haniloo A Parasitol Res; 2018 Jul; 117(7):2015-2023. PubMed ID: 29616349 [TBL] [Abstract][Full Text] [Related]
18. The action of albendazole on hydatid cysts in sheep experimentally infected with eggs of Echinococcus granulosus. Santos HT; Santos AF; de la Rue ML J Helminthol; 2008 Jun; 82(2):109-12. PubMed ID: 18199387 [TBL] [Abstract][Full Text] [Related]
19. [Effect of liposomal albendazole on the ultrastructure of Echinococcus granulosus cysts in mice]. Shao Y; Liu W; Wen H Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):292-3. PubMed ID: 12563861 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nanoparticles) against cystic echinococcosis. Gong Y; Zhou T; Ma R; Yang J; Zhao Y; Pan M; Huang Z; Wen H; Jiang H; Wang J BMC Infect Dis; 2024 Aug; 24(1):778. PubMed ID: 39097707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]